Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies.

about

P2860

Q42378932-45509CD8-3376-45FC-B1C2-19504B875CCB Q48184096-00F919C4-0436-41EB-A21E-C37284F187DE Q50479884-95C5D234-DFE6-4830-9A5B-290FAC39C7A2

P2860

Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies.

Item

http://www.wikidata.org/entity/Q42209543

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Circulating miRNAs are generic ...... rkers in muscular dystrophies.

@en

Circulating miRNAs are generic ...... rkers in muscular dystrophies.

@nl

type

Item

label

Circulating miRNAs are generic ...... rkers in muscular dystrophies.

@en

Circulating miRNAs are generic ...... rkers in muscular dystrophies.

@nl

prefLabel

Circulating miRNAs are generic ...... rkers in muscular dystrophies.

@en

Circulating miRNAs are generic ...... rkers in muscular dystrophies.

@nl

P1476

Circulating miRNAs are generic ...... rkers in muscular dystrophies.

@en

P2093

David Israeli

http://www.w3.org/2001/XMLSchema#string

Fatima Amor

http://www.w3.org/2001/XMLSchema#string

Isabelle Richard

http://www.w3.org/2001/XMLSchema#string

Jérôme Poupiot

http://www.w3.org/2001/XMLSchema#string

Karine Charton

http://www.w3.org/2001/XMLSchema#string

Laurence Jeanson-Leh

http://www.w3.org/2001/XMLSchema#string

P2860

miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy

Distinctive patterns of microRNA expression in primary muscular disorders

204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The Netherlands

A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells

Gene and cell-mediated therapies for muscular dystrophy.

Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice.

Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy

Sustained alpha-sarcoglycan gene expression after gene transfer in limb-girdle muscular dystrophy, type 2D.

Gene therapy for inherited muscle diseases: where genetics meets rehabilitation medicine.

Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy.

P2888

srep28097

P304

28097

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP28097

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

William Lostal

P577

2016-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1028062806

http://www.w3.org/2001/XMLSchema#string

P698

27323895

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

4914855

http://www.w3.org/2001/XMLSchema#string

Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies.

about

P2860

P2860

Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P6179

P698

P921

P932